- Subtitle:
- conference abstract
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
- Publisher:
- BMJ Publishing Group Limited Publisher's website
- Volume:
- 77
- Pages:
- 1010-1011
- Publication date:
- 2018-06-12
- DOI:
- EISSN:
-
1468-2060
- ISSN:
-
0003-4967
- Pubs id:
-
pubs:930945
- URN:
-
uri:34a929e9-eee5-4bfc-ab8d-f37def274b76
- UUID:
-
uuid:34a929e9-eee5-4bfc-ab8d-f37def274b76
- Local pid:
- pubs:930945
- Keywords:
- Copyright holder:
- Nash et al.
- Copyright date:
- 2018
- Notes:
- © 2018, Published by the BMJ Publishing Group Limited. This abstract was presented on the Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, June 13-16, 2018.
Conference item
Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, up to 36 months in patients with active psoriatic arthritis: data from the third interim analysis of opal balance, an open-label, long-term extension study
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record